Class 4 Medicines Notification: Argenx BV, Vyvgart 1000 mg solution for injection, EL (24)A/63
Argenx BV have informed MHRA that the Patient Information Leaflet (PIL) in the affected packs incorrectly contains reference to two subcutaneous injection sites. Only subcutaneous injection to the abdomen is permitted.
View Original Alert
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - General Practice
All alerts from this source
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest